Endocrinology and Hormones
Endocrinology and Hormones(内分泌和激素)
Endocrinology and Hormones
The endocrine system is an information signaling system that coordinates most bodily functions. It senses environmental changes and secretes corresponding hormones to coordinate metabolism, maintain homeostasis, and regulate growth and development.read more
Endocrinology and Hormones 相关产品(940)
- GC60857Frakefamide TFA纯度: >99.00%
FrakefamideTFA具有有效的止痛作用,是选择性的μ受体的外围激动剂。Frakefamide不能透过血脑屏障,进入中枢神经系统。
- GC61003Loperamide D6 hydrochlorideCAS: 1189469-46-2
LoperamideD6hydrochloride(R-18553D6hydrochloride)是Loperamidehydrochloride的氘代化合物。Loperamidehydrochloride是一种阿片受体(opioidreceptor)的激动剂,可用于腹泻的研究。
- GC61267SAR439859CAS: 2114339-57-8纯度: >99.50%
Amcenestrant (SAR439859, compound 43d) is an orally available and nonsteroidal selective estrogen receptor degrader (SERD) with potential antineoplastic activity. SAR439859 is a potent estrogen receptor (ER) antagonist with EC50 of 0.2 nM for ERα degradation.
- GC61481PROTAC AR Degrader-4 TFA纯度: >98.00%
PROTACARDegrader-4包含cIAP1配体结合基团,linker和雄激素受体(AR)配体结合基团。基于cIAP1的降解剂也被称为SNIPER。
- GC61484β-Casomorphin, human TFA纯度: >99.50%
β-Casomorphin,humanTFA(Humanβ-casomorphin7TFA)是一种阿片样肽,作为opioid受体激动剂。
- GC61491(R)-BicalutamideCAS: 113299-40-4纯度: >99.50%
(R)-Bicalutamide是Bicalutamide的R型对映体。(R)-Bicalutamide是一种雄激素受体(AR)拮抗剂,具有抗肿瘤活性。(R)-Bicalutamide广泛用于前列腺癌的研究。
- GC61586UFP-101 TFA纯度: >99.00%
UFP-101TFA是一种强效、选择性和竞争性的NOP受体拮抗剂,pKi为10.24。UFP-101TFA对δ、μ和κ类阿片受体的选择性大于3000倍。UFP-101TFA具有抗抑郁药样作用。
- GC61850Medroxyprogesterone acetate D3纯度: >98.00%
Medroxyprogesterone acetate D3 是 Medroxyprogesterone acetate 的氘代物。Medroxyprogesterone acetate 是一种广泛使用的合成类固醇,与孕酮 (progesterone),雄激素 (androgen) 和糖皮质激素受体 (glucocorticoid receptors) 都有作用。
- GC62106JNJ-63576253CAS: 2110428-64-1纯度: >99.00%
JNJ-63576253 (TRC-253) is a potent and selective androgen receptor (AR) Antagonist with IC50 of 6.9 nM. JNJ-63576253 displays robust inhibition in WT and LBD-mutated, enzalutamide-resistant models of prostate cancer.
- GC62124UT-34CAS: 2168525-92-4纯度: >98.00%
UT-34 is a potent, selective and orally bioavailable second-generation androgen receptor (AR) pan antagonist and degrader with IC50 of 203.46 nM, 80.78 nM and 94.17 nM for wild-type, T877A and W741L AR, respectively. UT-34 is a potential next-generation therapeutic for enzalutamide-resistant prostate cancer.
- GC62249Honokiol DCACAS: 1620160-42-0
Honokiol DCA (Honokiol dichloroacetate) 是 Honokiol 的二氯乙酸酯类似物。Honokiol DCA 在体外可以抑制人前列腺癌细胞的生长并抑制雄激素受体 (AR) 蛋白水平。
- GC62603Ralaniten triacetateCAS: 1637573-04-6纯度: >98.50%
Ralaniten triacetate (EPI-506) 是 Ralaniten 的前药,是一种首创的,具有口服活性的雄激素受体 (AR) N 端结构域 (NTD) 抑制剂。Ralaniten triacetate 对全长和与抗性相关的 AR 物种,包括 AR-v7 都有活性。
- GC62644GnRH antagonist 2CAS: 1709823-61-9纯度: >98.00%
GnRH antagonist 2 (formula I) 是一种 GnRH 受体拮抗剂,可用于子宫内膜异位的研究。
- GC627611α-Hydroxy-3-epi-vitamin D3CAS: 58028-00-5纯度: >99.00%
1α-Hydroxy-3-epi-vitamin D3 是 1alpha,25-dihydroxyvitamin D3 的天然代谢物,是甲状旁腺激素 (?PTH?) 分泌的有效抑制剂
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC60857 | Frakefamide TFA | - | >99.00% | |
FrakefamideTFA具有有效的止痛作用,是选择性的μ受体的外围激动剂。Frakefamide不能透过血脑屏障,进入中枢神经系统。 | ||||
| GC61003 | Loperamide D6 hydrochloride | 1189469-46-2 | - | |
LoperamideD6hydrochloride(R-18553D6hydrochloride)是Loperamidehydrochloride的氘代化合物。Loperamidehydrochloride是一种阿片受体(opioidreceptor)的激动剂,可用于腹泻的研究。 | ||||
| GC61010 | L-Thyroxine sodium | 1955-3-8 | >99.50% | |
A synthetic form of thyroxine | ||||
| GC61267 | SAR439859 | 2114339-57-8 | >99.50% | |
Amcenestrant (SAR439859, compound 43d) is an orally available and nonsteroidal selective estrogen receptor degrader (SERD) with potential antineoplastic activity. SAR439859 is a potent estrogen receptor (ER) antagonist with EC50 of 0.2 nM for ERα degradation. | ||||
| GC61397 | Asimadoline hydrochloride | 185951-07-9 | >99.50% | |
A potent κ-opioid receptor agonist | ||||
| GC61481 | PROTAC AR Degrader-4 TFA | - | >98.00% | |
PROTACARDegrader-4包含cIAP1配体结合基团,linker和雄激素受体(AR)配体结合基团。基于cIAP1的降解剂也被称为SNIPER。 | ||||
| GC61484 | β-Casomorphin, human TFA | - | >99.50% | |
β-Casomorphin,humanTFA(Humanβ-casomorphin7TFA)是一种阿片样肽,作为opioid受体激动剂。 | ||||
| GC61491 | (R)-Bicalutamide | 113299-40-4 | >99.50% | |
(R)-Bicalutamide是Bicalutamide的R型对映体。(R)-Bicalutamide是一种雄激素受体(AR)拮抗剂,具有抗肿瘤活性。(R)-Bicalutamide广泛用于前列腺癌的研究。 | ||||
| GC61586 | UFP-101 TFA | - | >99.00% | |
UFP-101TFA是一种强效、选择性和竞争性的NOP受体拮抗剂,pKi为10.24。UFP-101TFA对δ、μ和κ类阿片受体的选择性大于3000倍。UFP-101TFA具有抗抑郁药样作用。 | ||||
| GC61850 | Medroxyprogesterone acetate D3 | - | >98.00% | |
Medroxyprogesterone acetate D3 是 Medroxyprogesterone acetate 的氘代物。Medroxyprogesterone acetate 是一种广泛使用的合成类固醇,与孕酮 (progesterone),雄激素 (androgen) 和糖皮质激素受体 (glucocorticoid receptors) 都有作用。 | ||||
| GC61954 | Deltorphin 2 TFA | - | >98.00% | |
Deltorphin 2 TFA 是一种选择性的 δ 阿片受体肽激动剂。 | ||||
| GC61971 | Liarozole | 115575-11-6 | >98.50% | |
A CYP26A1 inhibitor | ||||
| GC62061 | Melengestrol acetate | 2919-66-6 | >99.50% | |
A synthetic progestogen | ||||
| GC62106 | JNJ-63576253 | 2110428-64-1 | >99.00% | |
JNJ-63576253 (TRC-253) is a potent and selective androgen receptor (AR) Antagonist with IC50 of 6.9 nM. JNJ-63576253 displays robust inhibition in WT and LBD-mutated, enzalutamide-resistant models of prostate cancer. | ||||
| GC62118 | ARV-110 | 2222112-77-6 | >99.00% | |
ARV-110是一种具有口服生物利用度的特异性雄激素受体(AR)PROTAC降解剂,可导致AR的泛素化和降解。 | ||||
| GC62124 | UT-34 | 2168525-92-4 | >98.00% | |
UT-34 is a potent, selective and orally bioavailable second-generation androgen receptor (AR) pan antagonist and degrader with IC50 of 203.46 nM, 80.78 nM and 94.17 nM for wild-type, T877A and W741L AR, respectively. UT-34 is a potential next-generation therapeutic for enzalutamide-resistant prostate cancer. | ||||
| GC62209 | CLP-3094 | 312749-73-8 | >99.00% | |
CLP-3094, a potent inhibitor targeting the binding function 3 (BF3) site of androgen receptor (AR), inhibits AR transcriptional activity with IC50 of 4 μM, also is a selective, potent GPR142 antagonist. | ||||
| GC62249 | Honokiol DCA | 1620160-42-0 | - | |
Honokiol DCA (Honokiol dichloroacetate) 是 Honokiol 的二氯乙酸酯类似物。Honokiol DCA 在体外可以抑制人前列腺癌细胞的生长并抑制雄激素受体 (AR) 蛋白水平。 | ||||
| GC62329 | VPC-14449 | 1621375-32-3 | >98.50% | |
VPC-14449 是一种有效和选择性的雄激素受体 DNA 结合结构域 (AR-DBD) 抑制剂,对全长人 AR 的 IC50 值为 0.34 μM。VPC-14449 可降低全长 AR 以及 AR 变体与染色质相互作用的能力。VPC-14449 可用于前列腺癌的研究。 | ||||
| GC62603 | Ralaniten triacetate | 1637573-04-6 | >98.50% | |
Ralaniten triacetate (EPI-506) 是 Ralaniten 的前药,是一种首创的,具有口服活性的雄激素受体 (AR) N 端结构域 (NTD) 抑制剂。Ralaniten triacetate 对全长和与抗性相关的 AR 物种,包括 AR-v7 都有活性。 | ||||
| GC62644 | GnRH antagonist 2 | 1709823-61-9 | >98.00% | |
GnRH antagonist 2 (formula I) 是一种 GnRH 受体拮抗剂,可用于子宫内膜异位的研究。 | ||||
| GC62683 | Ralaniten | 1203490-23-6 | >99.50% | |
Ralaniten (EPI-002) 是一种有效和具有口服活性的雄激素受体 N 端结构域 (AR-NTD) 拮抗剂。Ralaniten 抑制 AR 转录活性,IC50 值为 7.4 μM。Ralanites 可用于去势抵抗性前列腺癌 (CRPC) 的研究。 | ||||
| GC62761 | 1α-Hydroxy-3-epi-vitamin D3 | 58028-00-5 | >99.00% | |
1α-Hydroxy-3-epi-vitamin D3 是 1alpha,25-dihydroxyvitamin D3 的天然代谢物,是甲状旁腺激素 (?PTH?) 分泌的有效抑制剂 | ||||
| GC62992 | Glutaurine | 56488-60-9 | - | |
Glutaurine是从牛甲状旁腺中分离的一种生物活性二肽,可拮抗可的松与甲状腺素。 | ||||
